(Q46504507)

22 December 2017

title

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab (English)

1 reference

22 December 2017

1 reference

Eriksson P

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

22 December 2017

Journal of Internal Medicine

published in

1 reference

22 December 2017

volume

257

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

540-548

1 reference

22 December 2017

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Current Attitudes to the Therapy of Vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

Treating human autoimmune disease by depleting B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01494.X

10.1111/J.1365-2796.2005.01494.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017